Grant: Discovery Grants Program - Individual
University of Toronto
$30,000.00
Generating Innate Immune Diversity to Recognize Newly Emerging Pathogens
FY 2013-14
Summary
. Overview: Emergence of new and drug-resistant pathogens is a reality. Most of these pathogens contain thick carbohydrate coats that are rarely recognized by our classical antibodies (e.g., IgG). However, innate immune collectins are anti-carbohydrate antibody-like molecules, and readily recognize a range of microbes. We will determine whether tissue inflammation induces mutation in collectins such as lung surfactant proteins A and D (SP-A, SP-D), so that the mutant proteins can recognize and neutralize newly emerging pathogens. This mechanism could give an evolutionary advantage to the host animals and humans. Objectives: The objective of this project is to determine whether infection and inflammation generate a repertoire of ""anti-carbohydrate antibodies"" from innate immune collectin genes. Collectins or collagenous lectins have fibrillar collagen-like regions and globular carbohydrate-recognition domains (CRDs or lectin domains). These collectins bind carbohydrate moieties present on microbial surfaces and neutralize their infectivity. However, collectins are encoded by single copy genes, and do not undergo gene rearrangements or somatic mutations. Therefore, unlike antibodies, these genes do not have the classical ability to generate variant collectins. We will determine whether deamination of specific bases of mRNA results in the generation of point mutations in collectins during inflammation. New knowledge & potential outcome: Findings from this basic science study could represent a paradigm shift in the field of immunology. Our work will show whether the innate immune system instantly changes collectins SP-A and SP-D so that the mutant proteins can recognize newly emerging pathogens and prevent infectious diseases such as pneumonia (e.g., bacteria, virus, fungi). This mechanism could help to stop the emergence of new strains of influenza flu and multi-drug resistant pathogens. Our data will show whether the inflammation is a ""necessary evil"" during the fight against the newly emerging microbial pathogens, and that suppressing inflammation would weaken the ability of the host to fight against dangerous pathogens.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
436250-2013
Name nom
Palaniyar, Nades
Department département
Laboratory Medicine and Pathobiology
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
30000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
4700
Research subject group en
Evolution and ecology
Research subject group fr
Évolution et écologie
Research subject en
Evolution and ecology
Research subject fr
Évolution et écologie
Partie
1
Nb partie
5
Application title
Generating Innate Immune Diversity to Recognize Newly Emerging Pathogens
Keyword
NSERC
Application summary
. Overview: Emergence of new and drug-resistant pathogens is a reality. Most of these pathogens contain thick carbohydrate coats that are rarely recognized by our classical antibodies (e.g., IgG). However, innate immune collectins are anti-carbohydrate antibody-like molecules, and readily recognize a range of microbes. We will determine whether tissue inflammation induces mutation in collectins such as lung surfactant proteins A and D (SP-A, SP-D), so that the mutant proteins can recognize and neutralize newly emerging pathogens. This mechanism could give an evolutionary advantage to the host animals and humans. Objectives: The objective of this project is to determine whether infection and inflammation generate a repertoire of ""anti-carbohydrate antibodies"" from innate immune collectin genes. Collectins or collagenous lectins have fibrillar collagen-like regions and globular carbohydrate-recognition domains (CRDs or lectin domains). These collectins bind carbohydrate moieties present on microbial surfaces and neutralize their infectivity. However, collectins are encoded by single copy genes, and do not undergo gene rearrangements or somatic mutations. Therefore, unlike antibodies, these genes do not have the classical ability to generate variant collectins. We will determine whether deamination of specific bases of mRNA results in the generation of point mutations in collectins during inflammation. New knowledge & potential outcome: Findings from this basic science study could represent a paradigm shift in the field of immunology. Our work will show whether the innate immune system instantly changes collectins SP-A and SP-D so that the mutant proteins can recognize newly emerging pathogens and prevent infectious diseases such as pneumonia (e.g., bacteria, virus, fungi). This mechanism could help to stop the emergence of new strains of influenza flu and multi-drug resistant pathogens. Our data will show whether the inflammation is a ""necessary evil"" during the fight against the newly emerging microbial pathogens, and that suppressing inflammation would weaken the ability of the host to fight against dangerous pathogens.